Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec2cf2772a722c89d7cdeaf3f7f441cc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf3a308ab5bd5d267a0914318d61ae36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d5c670c2d30eb817a3d14dae0583441 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c56c845ecaec7f92fdfdd9bed2343da2 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-111 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
filingDate |
1996-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48bb2ebfce539d301ffc8d4ee6f5a164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00504f758e7b8a3e0d8ce11cd9d22868 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43df7ef1403e454b4224985ad0afd5f1 |
publicationDate |
1996-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9627664-A2 |
titleOfInvention |
Antisense transcript expressed in b lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof |
abstract |
An antisense transcript which complements the immature mRNA of the IgH gene, originates in the 3' region downstream the enhancer region (E) and terminates in the 5' region upstream the J region. Oligodeoxynucleotides directed to any region of said antisense transcript and their use for diagnostic or pharmaceutical purposes. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8140148-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005054506-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005054506-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0210190-A3 |
priorityDate |
1995-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |